01jun

Primary therapy and relative survival among elderly patients with chronic myeloid leukemia: a population-based study in the Netherlands, 1989-2017.

Auteurs: Ector GICG, Visser O, Westerweel PE, Janssen JJWM, Blijlevens NMA, Dinmohamed AG.
01jun

Response and Adherence to Nilotinib in Daily Practice (RAND Study): An In-Depth Observational Study of Chronic Myeloid Leukemia Patients Treated With Nilotinib.

Auteurs: Christel C L M Boons, Lonneke Timmers, Jeroen J W M Janssen, Peter E Westerweel, Nicole M A Blijlevens, Willem M Smit, Imke H Bartelink, Janneke A Wilschut, Eleonora L Swart, N Harry Hendrikse, Jacqueline G Hugtenburg.
01mei

Survival Continues to Increase in Chronic Lymphocytic Leukaemia: A Population-Based Analysis Among 20 468 Patients Diagnosed in the Netherlands Between 1989 and 2016.

Auteurs: Van der Straten L , Levin MD, Visser O, Posthuma EFM, Doorduijn JK, Kater AP, Dinmohamed AG
01mei

Long term follow up of mTOR inhibition for Erdheim-Chester disease.

Auteurs: Francesco Pegoraro, Valerio Maniscalco, Francesco Peyronel, Pieter J Westenend, Tadek R Hendriksz, Rosa M Roperto, Alessandro A Palumbo, Elena Sieni, Paola Romagnani, Eric F H van Bommel, Augusto Vaglio.
01mei

The Development of a Web-Based, Patient-Centered Intervention for Patients With Chronic Myeloid Leukemia (CMyLife): Design Thinking Development Approach.

Auteurs: Geneviève Icg Ector, Peter E Westerweel, Rosella Pmg Hermens, Karin Ae Braspenning, Barend Cm Heeren, Oscar Mf Vinck, Jan Jm de Jong, Jeroen Jwm Janssen, Nicole Ma Blijlevens.